Cargando…

Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events

PURPOSE: To capture UK societal health utility values for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and the disutility associated with treatment-related adverse events (AEs) to inform future cost–utility analyses. METHODS: A literature review, and patient and clinical expert int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hall, F., de Freitas, H. M., Kerr, C., Ito, T., Nafees, B., Lloyd, A. J., Penton, J., Hadi, M., Lanar, S., Pham, T. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470112/ https://www.ncbi.nlm.nih.gov/pubmed/30767088 http://dx.doi.org/10.1007/s11136-019-02117-9

Ejemplares similares

Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
por: Gould, A., et al.
Publicado: (2023)

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
por: Ng, Kenrick, et al.
Publicado: (2020)

Comparing costs and health care resource utilization between nmHSPC and mHSPC patients: a retrospective claims analysis
por: Ko, Gilbert Chao, et al.
Publicado: (2022)

Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?
por: Thomas, Christian, et al.
Publicado: (2021)

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
por: Reichert, Zachery R., et al.
Publicado: (2021)

Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
por: Ito, Tetsuro, et al.
Publicado: (2018)

(225)Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings
por: Sathekge, Mike, et al.
Publicado: (2023)

Disutility Study for Adult Patients with Moderate to Severe Crohn’s Disease
por: Worbes-Cerezo, Melany, et al.
Publicado: (2019)

SYSTEMIC TRIPLE THERAPY IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER (MHSPC)
por: Omrčen, Tomislav
Publicado: (2022)

Disutility associated with cancer screening programs: A systematic review
por: Li, Lin, et al.
Publicado: (2019)

It is not always about gains: utilities and disutilities associated with treatment features in patients with moderate-to-severe psoriasis
por: Umar, Nasir, et al.
Publicado: (2012)

Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment
por: Lu, Yuqiong, et al.
Publicado: (2023)

Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries
por: de Freitas, Hayley M., et al.
Publicado: (2019)

Re-examining HSPC1 inhibitors
por: Lee, Sheah Lin, et al.
Publicado: (2017)

HSPC300 and its role in neuronal connectivity
por: Qurashi, Abrar, et al.
Publicado: (2007)

Health state utilities for metastatic breast cancer
por: Lloyd, A, et al.
Publicado: (2006)

Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration
por: Omidvari, Amir-Houshang, et al.
Publicado: (2021)

Flow Dynamics and HSPC Homing in Bone Marrow Microvessels
por: Bixel, M. Gabriele, et al.
Publicado: (2017)

Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China
por: Hu, Shanlian, et al.
Publicado: (2023)

Geographic clonal tracking in macaques provides insights into HSPC migration and differentiation
por: Wu, Chuanfeng, et al.
Publicado: (2018)

Better Informing Decision Making with Multiple Outcomes Cost-Effectiveness Analysis under Uncertainty in Cost-Disutility Space
por: McCaffrey, Nikki, et al.
Publicado: (2015)

Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
por: McEwan, Phil, et al.
Publicado: (2022)

Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis
por: Lee, Man K.S., et al.
Publicado: (2022)

HSPC117 Is Regulated by Epigenetic Modification and Is Involved in the Migration of JEG-3 Cells
por: Ma, Hong, et al.
Publicado: (2014)

Promoter-Associated RNAs Regulate HSPC152 Gene Expression in Malignant Melanoma
por: Bonen, Hamutal, et al.
Publicado: (2016)

Bone marrow niche-mimetics modulate HSPC function via integrin signaling
por: Kräter, Martin, et al.
Publicado: (2017)

Mechanical Properties Determination of DMPC, DPPC, DSPC, and HSPC Solid-Ordered Bilayers
por: Drabik, Dominik, et al.
Publicado: (2020)

Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UK
por: Thompson, Alexander, et al.
Publicado: (2023)

Angiopoietin-like proteins stimulate HSPC development through interaction with notch receptor signaling
por: Lin, Michelle I, et al.
Publicado: (2015)

Predictors of Bone Metastases at (68)Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence
por: Rovera, Guido, et al.
Publicado: (2022)

ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in mice
por: Bloom, Mackenzie, et al.
Publicado: (2023)

Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source
por: Hess, Nicholas J., et al.
Publicado: (2020)

Loss of Dictyostelium HSPC300 causes a scar-like phenotype and loss of SCAR protein
por: Pollitt, Alice Y, et al.
Publicado: (2009)

The Molecular and Functional Interaction between ICln and HSPC038 Proteins Modulates the Regulation of Cell Volume
por: Dossena, Silvia, et al.
Publicado: (2011)

Expression and subcellular localization of HSPC117 in min pig tissues and the PK15 cell line
por: Ma, Hong, et al.
Publicado: (2019)

TGFβ Inhibitor A83-01 Enhances Murine HSPC Expansion for Gene Therapy
por: Fleischauer, Jenni, et al.
Publicado: (2023)

Event-free survival after (68) Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
por: Ceci, Francesco, et al.
Publicado: (2022)

Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients
por: Huang, Shanshan, et al.
Publicado: (2017)

Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
por: Dong, Yongpin, et al.
Publicado: (2021)

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome
por: Butt, Alison J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_u96rr1jjug86m7j18b0jc3q3ie